A step closer to autologous cell therapy for Parkinson's disease.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33798419.
- Also identified by DOI 10.1016/j.stem.2021.03.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a recent report in Nature Medicine, Tao et al. (2021) demonstrate that MPTP-treated monkeys receiving autologous, but not allogeneic, transplantation showed significant long-term improvement in motor and depressive behaviors, supporting the feasibility of autologous cell therapy for Parkinson's disease (PD).
Medical subject headings
- Parkinson Disease